Supernus Pharmaceuticals, Inc. (SUPN)

49.89 -1.36 (-2.65%) USD  |  NASDAQ  |  Dec 30, 16:00
49.00 -0.89 (-1.78%) After-Hours: 05:29
More

Supernus Pharmaceuticals Monthly Value at Risk (VaR) 5% (Since Inception)

Monthly Value at Risk (VaR) 5% (Since Inception) Chart

View Monthly Value at Risk (VaR) 5% (Since Inception) for SUPN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Monthly Value at Risk (VaR) 5% (Since Inception) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Value At Risk (VaR) Definition

View Value At Risk (VaR) Definition
Start Trial

The VaR calculates the potential loss of an investment with a given time frame and confidence level.

Read full definition.

Monthly Value at Risk (VaR) 5% (Since Inception) Range, Past 5 Years

View Monthly Value at Risk (VaR) 5% (Since Inception) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Monthly Value at Risk (VaR) 5% (Since Inception) Benchmarks

View Monthly Value at Risk (VaR) 5% (Since Inception) Benchmarks
Start Trial
BridgeBio Pharma, Inc. Upgrade
The Cooper Cos., Inc. Upgrade
Assembly Biosciences, Inc. Upgrade
Amphastar Pharmaceuticals, Inc. Upgrade
Viking Therapeutics, Inc. Upgrade

Monthly Value at Risk (VaR) 5% (Since Inception) Related Metrics

Alpha (Since Inception) Upgrade
Beta (Since Inception) Upgrade
Annualized Standard Deviation of Monthly Returns (Since Inception) Upgrade
Historical Sharpe Ratio (Since Inception) Upgrade
Historical Sortino (Since Inception) Upgrade
Max Drawdown (Since Inception) Upgrade